Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

Hepatology

Volumn 30, Issue 1, 1999, Pages 238-243

  Janssen, Harry L A ^a   Gerken, Guido ^b   Carreño, Vicente ^c   Marcellin, Patrick ^d   Naoumov, Nikolai V ^e   Craxi, Antonio ^f   Ring Larsen, Helmer ^g   Kitis, George ^h   Van Hattum, Jan ⁱ   De Vries, Richard A ^j   Michielsen, Peter P ^k   Ten Kate, Fiebo J W ^l   Hop, Wim C J ^a   Heijtink, Rudolf A ^m   Honkoop, Pieter ^a   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Fundacion Gimenez Diaz   (Spain)

^d BEAUJON HOSPITAL   (France)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^g International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^h George Papanikolaou   (Greece)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j RIJNSTATE HOSPITAL   (Netherlands)

^k ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EUROPE; FEMALE; HEPATITIS B; HUMAN; LIVER FUNCTION TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; VIRUS REPLICATION;

EID: 0033037480     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300113     Document Type: Article

References (21)

1. Niederau C, Heintges T, Lange S, Goldmann G, Niederau C, Mohr L, Häussinger D. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-1427.
2. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-634.
3. Fattovich G, Giustina G, Realdi G, Schalm SW, Corrocher R., and the European Concerted Action of Viral Hepatitis (EUROHEP). Long-term outcome of HBeAg positive patients with compensated cirrhosis treated with interferon alpha. HEPATOLOGY 1997;26:1338-1342
4. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, et al. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
5. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Hallahan C. Randomized controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology 1988;95:1318-1325.
6. Berk L, Schalm SW, De Man RA, Heijtink RA, Berthelot P, Brechot C, et al. Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multicentre randomized controlled trial. J Hepatol 1992;14:305-309.
7. Janssen HLA, Berk L, Heijtink RA, Kate ten FJW, Schalm SW. Alpha-interferon and zidovudine combination therapy for chronic hepatitis type B. Results of a randomized placebo-controlled trial. HEPATOLOGY 1993;17:383-388.
8. Heathcote J, Schalm SW, Ciancara J, Farrell G, Feinmann V, Shermann M, Dhillon AP, et al. Lamivudine and Intron A combination treatment in patients with chronic hepatitis B infection. J Hepatol 1998;28:S1-S43.
9. Krogsgaard K, Marcellin P, Trepo C, Berthelot P, Sanchez-Tapias JM, Bassendine M, et al. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. J Hepatol 1996;25:803-813.
10. Rakela J, Wood JR, Czaja AJ, O'Brien PC, Taswell HF, Bowyer BA, Lange SM, et al. Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective randomized treatment trial. Mayo Clin Proc 1990;65:1330-1335.
11. Saracco G, Mazzella G, Rosina F, Cancellieri C, Lattore V, Raise E, et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. HEPATOLOGY 1989;10:336-341.
12. Janssen HLA, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, et al. The antiviral effect of prolonged intermittent lymphoblastoid alpha-interferon treatment in chronic hepatitis B. Gut 1992;33:1094-1098.
13. Schalm SW. Eurohep. A European community sponsored concerted action on viral hepatitis: its rationale and execution. J Hepatol 1992;15: 1-3.
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
15. Knodell RG, Ishak KG, Black WC, Chan TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
16. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
17. Krogsgaard K, Christensen E, Bindslev N, Schalm SW, Andersen PK, Ring-Larsen H and the European Concerted Action on Viral Hepatitis (Eurohep). Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. J Hepatol 1996;25:795-802.
18. Scully LJ, Shein R, Karayiannis P, McDonald JA, Thomas HC. Lymphoblastoid interferon therapy of chronic hepatitis HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment. J Hepatol 1987;5:51-58.
19. Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors. HEPATOLOGY 1989;10:761-763.
20. Kuhns MC, McNamara AL, Cabal CM, Decker RH, Thiers V Brechot C, Tiollais P. A new assay for quantitative detection of hepatitis B viral DNA in human serum. In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease, New York: Alan Liss Inc., 1988.
21. Zaaijer HL, Borgter F, Cuypers HT, Hermus MC, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994;32:2088-2091.